Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.
Tsuruma T, Iwayama Y, Ohmura T, Katsuramaki T, Hata F, Furuhata T, Yamaguchi K, Kimura Y, Torigoe T, Toyota N, Yagihashi A, Hirohashi Y, Asanuma H, Shimozawa K, Okazaki M, Mizushima Y, Nomura N, Sato N, Hirata K. Tsuruma T, et al. Among authors: okazaki m. J Transl Med. 2008 May 10;6:24. doi: 10.1186/1479-5876-6-24. J Transl Med. 2008. PMID: 18471305 Free PMC article. Clinical Trial.
Survivin mRNA expression in patients with breast cancer.
Nasu S, Yagihashi A, Izawa A, Saito K, Asanuma K, Nakamura M, Kobayashi D, Okazaki M, Watanabe N. Nasu S, et al. Among authors: okazaki m. Anticancer Res. 2002 May-Jun;22(3):1839-43. Anticancer Res. 2002. PMID: 12168879
Gastric T-cell lymphoma associated with hemophagocytic syndrome.
Fukui R, Hata F, Yasoshima T, Denno R, Okazaki M, Kasai K, Sato M, Homma T, Ohno K, Yanai Y, Sogahata K, Nishimori H, Hirata K. Fukui R, et al. Among authors: okazaki m. World J Surg Oncol. 2004 Oct 19;2:34. doi: 10.1186/1477-7819-2-34. World J Surg Oncol. 2004. PMID: 15491503 Free PMC article.
A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.
Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N. Idenoue S, et al. Among authors: okazaki m. Clin Cancer Res. 2005 Feb 15;11(4):1474-82. doi: 10.1158/1078-0432.CCR-03-0817. Clin Cancer Res. 2005. PMID: 15746049
[Pharmacokinetics of S-1].
Hirata K, Horikoshi N, Tominaga K, Sohma K, Yamaguchi K, Okazaki M, Furuhata T, Sasaki K, Nakano Y, Ishizuka H, Yamada Y, Uno S, Taguchi T, Yamamitsu S, Shirasaka T. Hirata K, et al. Among authors: okazaki m. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:27-35. Gan To Kagaku Ryoho. 2006. PMID: 16897969 Review. Japanese.
The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy.
Oouchi A, Sakata K, Masuoka H, Tamakawa M, Nagakura H, Someya M, Nakata K, Asaishi K, Okazaki M, Okazaki Y, Ohmura T, Hareyama M, Hori M, Shimokawara I, Okazaki A, Watanabe Y, Yamada T, Yuyama T, Satoh T, Hirata K. Oouchi A, et al. Among authors: okazaki a, okazaki m, okazaki y. Breast Cancer. 2009;16(1):49-57. doi: 10.1007/s12282-008-0079-3. Epub 2008 Oct 8. Breast Cancer. 2009. PMID: 18841332
1,708 results